MEDPLUS evidence report
Evidence date: 2026-10-01. Research observations only.
What can I do with this stock?
Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.
Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.
Today: intraday
Evidence unavailable
No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.
- No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.
Next week: five trading sessions
No qualifying opportunity
No candidate with a primary five-session horizon in the coherent source run.
- No candidate with a primary five-session horizon in the coherent source run.
Long term: one to three years
Research only
A financial screen alone does not establish an investment recommendation.
- A current, source-backed thesis and valuation review is required.
Investment evidence
- Statement coverage
- FULL_STATEMENTS
- Financial source retrieved
- 2026-09-22T14:02:08.182121+00:00
Metrics
- latest_annual_period
- 2026-03-31
- revenue
- 68924660000.0
- net_income
- 2196490000.0
- operating_cash_flow
- 5269940000.0
- free_cash_flow
- 4039640000.0
- total_assets
- 39325260000.0
- total_liabilities
- 19578720000.0
- total_equity
- 19753590000.0
- cash
- 4621620000.0
- total_debt
- 14243830000.0
- revenue_growth
- 0.12327354408444657
- earnings_growth
- 0.4611899788454119
- net_margin
- 0.031867984550087006
- roe
- 0.11119447148594255
- debt_to_equity
- 0.7210755108311957
- cash_conversion
- 2.3992551753024145
- free_cash_flow_margin
- 0.05860950202728603
- trailing_pe
- Not supplied
- forward_pe
- Not supplied
- peg_ratio
- Not supplied
- price_to_book
- Not supplied
- dividend_yield
- Not supplied
Other positional research
No qualifying opportunity
No candidate at another positional horizon in the coherent source run.
- No candidate at another positional horizon in the coherent source run.
Decision provenance and limitations
- Decision ID
- decision-efa2602e464a9e5e76d46896bb4b0783d00c8d8b771c8202cfe1fe30a60fc9ae
- Policy
- stock-decisions-v1
- Evidence bundle hash
- d3c3d8512f2a0b8e9c4325959009438eb897264023a7b2d7924392a92d69c2df
- market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
- validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
- financial-statements: 94444c58db1d7ba53b75310dcd8ef08c9b4f85edcdbf7c6c454c84265d9954d2
- daily-price: de2ba9e29948bf66f8072a3611eb9d690b267f264e0f56545c991cec67f09f70
- Conditional research decisions are not orders or personalized position sizes.
- Scenario payoffs are assumptions, not probabilities or expected returns.
- A stop price does not guarantee a maximum loss through a gap or illiquidity.
Download the decision evidence as JSON
Numerical report available. Evidence briefing is queued or awaiting retry.
Cached observations and evidence limits
- Price source verification: REPAIRED.
- The cached closing price on 2026-10-01 was INR 654.30.
- The trailing 5-session price return was 0.01%.
- The trailing 20-session price return was -0.86%.
- The trailing 60-session price return was -19.84%.
- The trailing 250-session price return was -18.13%.
- Average cached traded value over twenty sessions was INR 64,802,076.
- The closing price was -31.41% below its highest close in the available trailing year.
- Fundamental coverage is FULL_STATEMENTS; retrieved 2026-09-22T14:02:08.182121+00:00 from EODHD.
- The cached financial metric latest annual period is 2026-03-31.
- The cached financial metric revenue growth is 0.12327354408444657.
- The cached financial metric net margin is 0.031867984550087006.
- The cached financial metric roe is 0.11119447148594255.
- The cached financial metric debt to equity is 0.7210755108311957.
- The cached financial metric cash conversion is 2.3992551753024145.
- The cached financial metric free cash flow margin is 0.05860950202728603.
- Historical observations do not establish future returns. No verified current news or catalyst evidence is supplied.